Drug Pipeline

Lemborexant Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
5
Active Studies
3
Recruiting
5
Top Sponsors
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-12 NCT07384429
Effects of Lemborexant on Motor-sleep Comorbidity in Parkinson's Disease		 overall status: "Recruiting" → "Not Yet Recruiting"
Active Studies by Phase
Phase 4
3
Phase 2
2
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT06874855 Lemborexant in Delayed Sleep Phase Syndrome Delayed Sleep Phase Syndrome Recruiting
NCT07407400 Lemborexant for Sleep and Delirium Prevention in Elderly ICU Patients Sleep Disturbance Not Yet Recruiting
NCT07384429 Effects of Lemborexant on Motor-sleep Comorbidity in Parkinson's Disease Parkinson's Disease Not Yet Recruiting
Phase 2
NCT06274528 DORA and LP in Alzheimer's Disease Biomarkers Alzheimer Disease Recruiting
NCT06843187 Lemborexant for the Treatment of Residual Insomnia in Major Depressive Disorder (MDD) Major Depressive Disorder(MDD) Recruiting
Sponsors Running Lemborexant Trials
Washington University School of Medicine (1) Unity Health Toronto (1) University of California, San Francisco (1) YangPan (1) Mahidol University (1)
Disease Areas
Alzheimer's Disease (1) Depression (1) Parkinson's Disease (1)
Get alerts when Lemborexant trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free